FDA Alerts

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The FDA has approved the first treatment for eosinophilic esophagitis.

A new treatment option for the management of blood sugar in individuals with type 2 diabetes is approved under FDA priority review designation.

To reduce the amount of tobacco-related disease and death in the United States, the FDA is proposing additional action on flavored cigarettes and cigars.

The US Food and Drug Administration has approved a new medication therapy for the treatment of metastatic and unresectable melanoma.

A generic drug-product combination for the treatment of asthma and COPD was just approved by the US Food and Drug Administration.

The US Food and Drug Administration has approved a treatment option for adults with heart failure.

The US Food and Drug Administration has approved a second vaccine for the prevention of COVID-19.

The US Food and Drug Administration has approved the drug based on the results from the KEEPsAKE-1 and KEEPsAKE-2 randomized, placebo-controlled studies.

The drug is approved as a diagnostic tool to help identify cancerous lesions during surgery, which is normally difficult to detect. The drug is administered intravenously prior to surgery.